FDA-approved drug may help to decrease pain after surgery, study finds

Researchers in the Department of Anesthesia and Perioperative Medicine at the Medical University of South Carolina (MUSC) have found that an FDA-approved drug may help to decrease pain after surgery.

Roundup: Medtech M&A slump continues but analysts predict uptick in 2024

Medtech M&A was down for the second straight year after an explosion of deal-making in 2021, with deal volumes down compared to prior years and

December 19, 2023

Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO | Psychedelic Invest

Mydecine Innovations Group Inc. (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with

October 5, 2023

Q&A: Vertex’s pain research chief on moving beyond opioids, AI and how pharma acquisitions thrive or fail

SAN DIEGO — For savvy dealmaking, Vertex’s 2001 acquisition of Aurora Biosciences is near the top of the list. Vertex bought the San Diego biotech

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.